IMSA101

· ImmuneSensor Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IMSA101, covering 2024-11-18 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC [Phase 2]